Ultrasonographic evaluation of lansoprazole-induced improvement of submucosal injury in patients with gastroesophageal reflux

American Journal of Gastroenterology

Volumn 95, Issue 2, 2000, Pages 381-386

  Mine, Shinichiro ^a   Fujisaki, Takeshi ^a   Tabata, Takahiro ^a   Matsuoka, Hirofumi ^a   Iida, Takeshi ^a   Yamada, Shinwa ^a   Tanaka, Yoshiya ^a   Morimoto, Isao ^a   Eto, Sumiya ^a   Aibe, Takeshi ^b  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b YAMAGUCHI ROSAI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDOSCOPIC ECHOGRAPHY; ESOPHAGUS INJURY; ESOPHAGUS MUSCLE; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBMUCOSA; THICKNESS;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; ENDOSONOGRAPHY; ENZYME INHIBITORS; ESOPHAGITIS, PEPTIC; ESOPHAGUS; FAMOTIDINE; FEMALE; GASTROESOPHAGEAL REFLUX; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; MUCOUS MEMBRANE; MUSCLE, SMOOTH; OMEPRAZOLE; PROTON PUMPS;

EID: 18744427362     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00816-3     Document Type: Article

References (28)

1. Castell D.O., Richter J.E., Robinson M., et al. Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. Am J Gastroenterol. 91:1996;1749-1757.
2. Parkmann H.P., Schwartz S.S. Esophagitis and gastroduodenal disorder associated with diabetic gastroparesis. Arch Intern Med. 147:1987;1477-1480.
3. Murphy J.R., McNally P., Peller P., et al. Prolonged clearance is the primary abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitis. Dig Dis Sci. 37:1992;833-841.
4. Triadafilopoulos G., Sharma R. Feature of symptomatic gastroesophageal reflux disease in elderly patients. Am J Gastroenterol. 92:1997;2007-2011.
5. Caletti G.C., Ferrari A., Mattioli S., et al. Endoscopy versus endoscopic ultrasonography in staging reflux esophagitis. Endoscopy. 26:1994;794-797.
6. Harris R.A., Kuppermann M., Richter J.E. Proton pump inhibitor or histamine-2 receptor antagonists for the prevention of recurrence of erosive reflux esophagitis A cost-effectiveness analysis . Am J Gastroenterol. 92:1997;2179-2187.
7. Caletti G.C., Bolondi L., Zani L., et al. Technique of endoscopic ultrasonography investigation Esophagus, stomach and duodenum . Scand J Gastroenterol. 21:(suppl 123):1986;1-5.
8. Tsukamoto Y., Goto H., Hase S., et al. Endosonographic evaluation of the quality of ulcer healing induced by proton pump inhibitors. J Clin Gastroenterol. 20:(suppl 2):1995;S40-S43.
9. Spencer C.M., Faulds D. Lansoprazole A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders . Drugs. 48:1994;404-430.
10. Petite J.-P., Slama J.-L., Licht H., et al. Lansoprazole and omeprazole in the treatment of duodenal ulcer A multicentric double-blind comparative trial . Gastroenterol Clin Biol. 17:1993;334-340.
11. Florent C., Forestier S., Joubert-Collin M. Lansoprazole versus omeprazole Efficacy and safety in acute gastric ulcer . Gastroenterology. 104:(suppl):1993;A80. (abstract).
12. 2-receptor antagonist therapy. Am J Gastroenterol. 92:1997;429-437.
13. Armstrong D., Bennett J.R., Blum A.L., et al. The endoscopic assessment of esophagus A progress report on observer agreement . Gastroenterology. 111:1996;85-92.
14. Beck I.T., Champion M.C., Lemire S., et al. The second Canadian consensus conference on the management of patients with gastroesophageal reflux disease. Can J Gastroenterol. 11:(suppl B):1997;7B-20B.
15. Caletti G.C., Ferrari A., Barbara L. Normal endosonographic anatomy of the esophagus and stomach. Gastrointest Endosc Clin N Am. 2:1992;601-614.
16. Caletti G.C., Fusaroli P., Bocus P. Endoscopic ultrasonography. Digestion. 59:1998;509-529.
17. Kawamura O., Sekiguchi T., Kusano M., et al. Endoscopic ultrasonographic abnormalities and lower esophageal sphincter function in reflux esophagitis. Dig Dis Sci. 40:1995;598-605.
18. Havelund T., Aalykke C. The efficacy of a pectin-based raft-forming anti-reflux agent in endoscopy-negative reflux disease. Scand J Gastroenterol. 32:1997;773-777.
19. Wiklund I., Bardhan K.D., Muller-Lissner S., et al. Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European study group. Ital J Gastroenterol Hepatol. 30:1998;19-27.
20. 2RA-resistant erosive reflux esophagitis. Gastroenterology. 98:1990;A113. (abstract).
21. 2-receptor antagonist therapy. Am J Gastroenterol. 88:1993;1212-1217.
22. Benhaim M.C., Evreux M., Salducci J., et al. Lansoprazole and ranitidine in treatment of reflux esophagitis Double blind comparative trial . Gastroenterology. 98:1990;A20. (abstract).
23. Bardhan K.D., Long R., Hawkey C.J., et al. Lansoprazole, a new proton pump inhibitor, vs ranitidine in the treatment of reflux erosive esophagitis. Gastroenterology. 100:1991;A30. (abstract).
24. Robinson M., Kogut D., Jennings D., et al. Lansoprazole heals erosive reflux esophagitis better than ranitidine. Gastroenterology. 102:1992;A153. (abstract).
25. 2-receptor antagonist therapy. Am J Gastroenterol. 92:1997;429-437.
26. Sontag S.J. The medical management of reflux esophagitis. Role of antacids and acid inhibition. Gastroenterol Clin North Am. 19:1990;683-712.
27. 2-receptor antagonists. Scand J Gastroenterol. 24:(suppl 166):1989;88-93.
28. 2-receptor antagonist therapy. Dig Dis Sci. 40:1995;590-597.